BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 29091305)

  • 1. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J; Liu L; Zou H; Yu W
    Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
    Chen L; Yao H; Wang K; Liu X
    J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.
    Zhao L; Zhang Y; Zhang Y
    J Cell Physiol; 2018 Oct; 233(10):6661-6670. PubMed ID: 29319182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
    Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
    J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
    Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
    J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
    Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis.
    Zou Y; Sun Z; Sun S
    J Biochem; 2020 Nov; 168(5):535-546. PubMed ID: 32663252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ; Yang JB
    Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
    Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y
    Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
    Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
    Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
    Yin J; Liu Q; Chen C; Liu W
    J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.